173 related articles for article (PubMed ID: 37673973)
1. CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
Bauer K; Machherndl-Spandl S; Kazianka L; Sadovnik I; Gültekin S; Suessner S; Proell J; Lauf J; Hoermann G; Eisenwort G; Häfner N; Födermayr-Mayrleitner M; Schmolke AS; van der Kouwe E; Platzbecker U; Lion T; Weltermann A; Zach O; Webersinke G; Germing U; Gabriel C; Sperr WR; Béné MC; Staber PB; Bettelheim P; Valent P
Leukemia; 2023 Nov; 37(11):2250-2260. PubMed ID: 37673973
[TBL] [Abstract][Full Text] [Related]
2. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
3. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders.
Cortelezzi A; Colombo G; Pellegrini C; Silvestris I; Moronetti Mazzeo L; Bosari S; Lambertenghi Deliliers G; Fracchiolla NS
Am J Hematol; 2008 Jul; 83(7):531-9. PubMed ID: 18383321
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
Della Porta MG; Malcovati L; Invernizzi R; Travaglino E; Pascutto C; Maffioli M; Gallì A; Boggi S; Pietra D; Vanelli L; Marseglia C; Levi S; Arosio P; Lazzarino M; Cazzola M
Leukemia; 2006 Apr; 20(4):549-55. PubMed ID: 16498394
[TBL] [Abstract][Full Text] [Related]
7. CD36 relative mean fluorescence intensity of CD105
Lu Y; Chen X; Zhang L
Sci Rep; 2023 Jun; 13(1):8930. PubMed ID: 37264109
[TBL] [Abstract][Full Text] [Related]
8. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor alterations in myelodysplastic syndrome.
Wei Y; Dimicoli S; Bueso-Ramos C; Chen R; Yang H; Neuberg D; Pierce S; Jia Y; Zheng H; Wang H; Wang X; Nguyen M; Wang SA; Ebert B; Bejar R; Levine R; Abdel-Wahab O; Kleppe M; Ganan-Gomez I; Kantarjian H; Garcia-Manero G
Leukemia; 2013 Sep; 27(9):1832-40. PubMed ID: 23765228
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis.
Lammers R; Giesert C; Grünebach F; Marxer A; Vogel W; Bühring HJ
Exp Hematol; 2002 Jun; 30(6):537-45. PubMed ID: 12063020
[TBL] [Abstract][Full Text] [Related]
12. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.
Claessens YE; Park S; Dubart-Kupperschmitt A; Mariot V; Garrido C; Chrétien S; Dreyfus F; Lacombe C; Mayeux P; Fontenay M
Blood; 2005 May; 105(10):4035-42. PubMed ID: 15677568
[TBL] [Abstract][Full Text] [Related]
13. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V
Clin Cancer Res; 2012 Jun; 18(11):3079-89. PubMed ID: 22496271
[TBL] [Abstract][Full Text] [Related]
14. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
[TBL] [Abstract][Full Text] [Related]
15. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
16. Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.
Kornblau SM; Cohen AC; Soper D; Huang YW; Cesano A
Cytometry B Clin Cytom; 2014 Nov; 86(6):383-96. PubMed ID: 24106013
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
[TBL] [Abstract][Full Text] [Related]
18. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
19. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
20. Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency.
Sen T; Jain M; Gram M; Mattebo A; Soneji S; Walkley CR; Singbrant S
Exp Hematol; 2020 Aug; 88():28-41. PubMed ID: 32629063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
